A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE

被引：6

作者：

Descamps, Olivier S. ^{[1
,2
]}

Cooney, Marie Therese ^{[3
]}

De Backer, Guy ^{[4
]}

Graham, Ian ^{[3
]}

机构：

[1] Hop Jolimont, Ctr Rech Med Jolimont, B-7100 Haine St Paul, Belgium

[2] Hop Jolimont, Dept Med Interne, B-7100 Haine St Paul, Belgium

[3] Adelaide & Meath Hosp, Dept Cardiol, Dublin 24, Ireland

[4] Ghent Univ Hosp, Dept Cardiol, Ghent, Belgium

来源：

ATHEROSCLEROSIS | 2012年 / 222卷 / 02期

关键词：

SCORE; Cardiovascular risk; Risk assessment; Prevention; HDL cholesterol; Guidelines; GUIDELINES; DISEASE;

D O I：

10.1016/j.atherosclerosis.2012.03.035

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The 2011 ESC-EAS guidelines on the management of dyslipidaemias use four separate charts to illustrate the impact of differing HDL cholesterol levels on risk of cardiovascular disease. We developed an easy way to calculate the effects of differing HDL-C levels on risk by deriving HDL and sex specific multipliers and applying these to various reference charts. Of three strategies explored, one based on a low HDL (0.8 mmol/l) reference chart was the simplest and was acceptably accurate. Such an approach simplifies risk estimation by avoiding the need for multiple charts. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

引用

页码：564 / 566

页数：3

共 50 条

[21] Non-HDL Cholesterol Shows Improved Accuracy for Cardiovascular Risk Score Classification Compared to Direct or Calculated LDL Cholesterol in a Dyslipidemic Population
van Deventer, Hendrick E.
Miller, W. Greg
Myers, Gary L.
Sakurabayashi, Ikunosuke
Bachmann, Lorin M.
Caudill, Samuel P.
Dziekonski, Andrzej
Edwards, Selvin
Kimberly, Mary M.
Korzun, William J.
Leary, Elizabeth T.
Nakajima, Katsuyuki
Nakamura, Masakazu
Shamburek, Robert D.
Vetrovec, George W.
Warnick, G. Russell
Remaley, Alan T.
CLINICAL CHEMISTRY, 2011, 57 (03) : 490 - 501
[22] Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated ldl cholesterol in a dyslipidemic population
van Deventer, Hendrick E.
Miller, W. Greg
Myers, Gary L.
Sakurabayashi, Ikunosuke
Bachmann, Lorin M.
Caudill, Samuel P.
Dziekonski, Andrzej
Edwards, Selvin
Kimberly, Mary M.
Korzun, William J.
Leary, Elizabeth T.
Nakajima, Katsuyuki
Nakamura, Masakazu
Shamburek, Robert D.
Vetrovec, George W.
Warnick, G. Russell
Remaley, Alan T.
ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2011, 45 (04): : 773 - 784
[23] Simple indices for estimation of cardiovascular risk
Kahl, S.
DIABETOLOGIE, 2023, 19 (03): : 357 - 358
[24] Unanswered questions in including HDL-cholesterol in the cardiovascular risk estimation. Is time still on our side?
Langlois, Michel R.
Delanghe, Joris R.
De Buyzere, Marc
Rietzschel, Ernst
De Bacquer, Dirk
ATHEROSCLEROSIS, 2013, 226 (01) : 296 - 298
[25] CARDIOVASCULAR RISK-FACTORS AND HDL-CHOLESTEROL LEVELS IN OBESITY
BERCHTOLD, P
BERGER, M
JORGENS, V
DAWEKE, C
CHANTELAU, E
GRIES, FA
ZIMMERMANN, H
INTERNATIONAL JOURNAL OF OBESITY, 1981, 5 (01) : 1 - 10
[26] Non-HDL Cholesterol and Long-Term cardiovascular risk
Wolfram, Guenther
AKTUELLE ERNAHRUNGSMEDIZIN, 2020, 45 (03): : 159 - 160
[27] Systemic Inflammation and the Dynamics of HDL Cholesterol–Associated Residual Cardiovascular Risk
Robert S. Rosenson
Current Atherosclerosis Reports, 2011, 13 (3) : 187 - 189
[28] Should we target HDL cholesterol level in lowering cardiovascular risk?
Toth, Peter P.
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (10): : 667 - 671
[29] Improving the prediction of cardiovascular risk: Interaction between LDL and HDL cholesterol
Grover, SA
Dorais, M
Coupal, L
EPIDEMIOLOGY, 2003, 14 (03) : 315 - 320
[30] HDL-cholesterol: an important factor to evaluate a cardiovascular risk in practice
Guinchard-Foulon, E
Rodriguez-Lafrasse, C
Rousson, R
ANNALES DE BIOLOGIE CLINIQUE, 2003, 61 (05) : 549 - 556

← 1 2 3 4 5 →